Chicago, IL -- (SBWIRE) -- 12/04/2013 -- PennyPicks.net prowls the markets, sifts through hundreds of companies and picks those positioned to move and then presents them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.Let’s have a look at today’s hot stocks: all companies Athersys, Inc.(NASDAQ:ATHX), Generex Biotechnology Corporation(OTCMKTS:GNBT), Amarin Corporation plc (ADR)(NASDAQ:AMRN), Cell Therapeutics Inc(NASDAQ:CTIC)
Athersys, Inc.(NASDAQ:ATHX) stock is at $2.13, up 1.91%. The stock opened the last trading session at $2.1 and touched its highest price point at $2.15. Its lowest price point for the session stood at $2.10.Its total trading volume is 1.25M shares for the day
Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
What ATHX Charts Are Signaling for Traders? Find Out Here
Generex Biotechnology Corporation(OTCMKTS:GNBT) stock closed at $0.0305, up 4.10%. Its today’s volume is 3.08M shares, in comparison to its average trading volume of 1.50M shares. The stock opened the session at $0.03 and touched its highest price point at $0.03.
The lowest price point for the stock stood at $0.03 whereas its 52 week price range stands at $0.02- $0.07.
Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Is GNBT Buy After The Recent Price Movement? Find Out Here
Amarin Corporation plc (ADR)(NASDAQ:AMRN) opened the session at $1.89 and remained in the $1.81 to $1.97 price range during the session. The stock is 1.10 % up at $1.84. Volume at the close was at 4.91M shares with its average volume being 7.92M shares.
Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Should AMRN a Buy or Sell Now? Find Out Here
Cell Therapeutics Inc(NASDAQ:CTIC) traded in the range of $1.96 and $2.05 in its previous trading session. The stock recorded the volume of 3.19 million shares, in comparison to its average daily trading volume of 3.43M shares.
The stock opened at $2.04 and its closing price for the day was $1.96, up 1.03%.
Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
What CTIC Charts Are Signaling for Traders? Find Out Here
For the best penny stock pickspenny stocks visit us at www.pennypicks.net
Our approach to penny stocks is completely different from most other sites out there. We prowl the markets, sift through hundreds of companies and pick those poised to move and then present them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.
Please fully understand this disclaimer before using our site or joining our email list. If you have any questions please contact us at firstname.lastname@example.org
PennyPicks.net is a private membership service that specializes in providing opinions, comments and information on stocks to individuals who wish to receive them. Our reports are for information and entertainment purposes only and are distributed free of charge exclusively to individuals who wish to receive them.
Read More at: http://www.pennypicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)